amphetamine has been researched along with olanzapine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 13 (56.52) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Rasmussen, K; Stockton, ME | 1 |
| Carl, KL; Holloway, FA; Mechanic, JA; Wasielewski, JA | 1 |
| Holloway, FA; Maynard, BT; Mechanic, JA | 1 |
| Deitemeyer, N; Dobner, PR; Egnatashvili, V; Kinkead, B; Murray, T; Nemeroff, CB | 1 |
| Kruse, CG; McCreary, AC; Olijslagers, JE; Perlstein, B; Siarey, R; Wadman, WJ; Werkman, TR | 1 |
| Chen, G; Creson, TK; Engel, SR; Hao, Y; Landreth, GE; Maeng, S; Manji, HK; Nekrasova, T; Shen, Y | 1 |
| Crabbe, JC; Philibin, SD; Porter, JH; Vunck, SA; Walentiny, DM | 1 |
| Azar, MR; Geyer, MA; Gold, L; Marston, HM; Martin, FD; Meltzer, LT; Moore, CL; Serpa, KA; Shahid, M; Wong, EH; Young, JW | 1 |
| Gnoatto, J; Lara, DR; Moreira, JD; Muller, AP; Perry, ML; Portela, LV; Souza, DO; Tort, AH; Vinadé, ER | 1 |
| Li, M; Mead, A; Sun, T | 1 |
| Bédard, AM; Lévesque, D; Maheux, J; Samaha, AN | 1 |
| Arenovich, T; Chintoh, A; Cohn, T; Fletcher, P; Giacca, A; Guenette, M; Hahn, MK; Lam, L; Mann, S; Nobrega, J; Remington, G; Teo, C | 1 |
| Bidder, M; Gil-Ad, I; Kramer, M; Portnoy, M; Taler, M; Tarasenko, I; Weizman, A | 1 |
| Bédard, AM; El Hage, C; Samaha, AN | 1 |
| Chou, S; Jones, S; Li, M | 1 |
| Gosden, J; Heal, D; Hutson, PH; Kulkarni, RS; Love, PL; Rowley, HL; Slater, N; Wang, Y | 1 |
| Ahnaou, A; Drinkenburg, WHIM; Huysmans, H; Van de Casteele, T | 1 |
| Chen, X; Fan, Q; Song, Y; Tang, J; Xue, X; Yu, X | 1 |
| Cannon, CE; Henze, DA; Lange, HS; Puri, V; Uslaner, JM; Vardigan, JD | 1 |
1 review(s) available for amphetamine and olanzapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for amphetamine and olanzapine
| Article | Year |
|---|---|
Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants: A randomized controlled trial.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Central Nervous System Stimulants; Female; Haloperidol; Humans; Male; Mental Disorders; Olanzapine; Research Design; Treatment Outcome | 2018 |
21 other study(ies) available for amphetamine and olanzapine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine Agents; Electrophysiology; Male; Mesencephalon; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley | 1996 |
Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Conditioning, Operant; Cues; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reinforcement Schedule | 2002 |
Treatment with the atypical antipsychotic, olanzapine, prevents the expression of amphetamine-induced place conditioning in the rat.
Topics: Amphetamine; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Central Nervous System Stimulants; Drug Interactions; Male; Olanzapine; Physical Conditioning, Animal; Pirenzepine; Rats; Rats, Sprague-Dawley; Substance-Related Disorders | 2003 |
Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Clozapine; Dibenzothiazepines; Female; Haloperidol; Male; Mice; Mice, Inbred C57BL; Neurotensin; Olanzapine; Quetiapine Fumarate; Reflex; Reflex, Startle | 2005 |
The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro.
Topics: Action Potentials; Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluorobenzenes; In Vitro Techniques; Male; Mesencephalon; Neural Inhibition; Neurons; Olanzapine; Piperidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Serotonin 5-HT2 Receptor Antagonists; Sulpiride | 2005 |
The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement.
Topics: Adjuvants, Immunologic; Administration, Oral; Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Central Nervous System Stimulants; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Lithium Chloride; Locomotion; Maze Learning; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Olanzapine; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Swimming; Valproic Acid | 2009 |
A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Discrimination Learning; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Olanzapine; Risperidone | 2008 |
Asenapine effects in animal models of psychosis and cognitive function.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Attention; Benzodiazepines; Cognition; Dibenzocycloheptenes; Disease Models, Animal; Dose-Response Relationship, Drug; Heterocyclic Compounds, 4 or More Rings; Male; Olanzapine; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Risperidone | 2009 |
Metabolic and behavioral effects of chronic olanzapine treatment and cafeteria diet in rats.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Diet; Dietary Fats; Eating; Fast Foods; Glucose Intolerance; Humans; Male; Maze Learning; Motor Activity; Obesity; Olanzapine; Rats; Rats, Wistar | 2010 |
Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.
Topics: Acoustic Stimulation; Amphetamine; Analysis of Variance; Animals; Avoidance Learning; Benzodiazepines; Clozapine; Conditioning, Classical; Dose-Response Relationship, Drug; Inhibition, Psychological; Male; Olanzapine; Phencyclidine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Time Factors | 2012 |
Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Conditioning, Classical; Cues; Diagnosis, Dual (Psychiatry); Dopamine; Dopamine Agents; Drug-Seeking Behavior; Haloperidol; Male; Motivation; Neostriatum; Olanzapine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Reward; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 2013 |
Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: an animal model.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Blood Glucose; C-Peptide; Central Nervous System Stimulants; Glucose; Infusions, Intraventricular; Insulin; Insulin Secretion; Liver; Male; Motor Activity; Olanzapine; Rats; Rats, Sprague-Dawley | 2014 |
A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia.
Topics: Alanine; Amphetamine; Animals; Antipsychotic Agents; Anxiety; Benzodiazepines; Brain; Central Nervous System Stimulants; Depression; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Exploratory Behavior; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Motor Activity; Olanzapine; Phencyclidine; Psychomotor Agitation; Schizophrenia; Social Behavior | 2014 |
Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Conditioning, Operant; Dopamine; Dopamine Agonists; Drug Resistance; GABA Agonists; Haloperidol; Male; Motor Activity; Nucleus Accumbens; Olanzapine; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, GABA; Reward | 2015 |
Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia.
Topics: Amphetamine; Animals; Animals, Newborn; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Cell Proliferation; Central Nervous System Stimulants; Disease Models, Animal; Female; Hippocampus; Hyperkinesis; Male; Maternal Deprivation; Motor Activity; Olanzapine; Poly I-C; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Reflex, Abnormal; Schizophrenia; Stem Cells; Vocalization, Animal | 2015 |
The effects in rats of lisdexamfetamine in combination with olanzapine on mesocorticolimbic dopamine efflux, striatal dopamine D2 receptor occupancy and stimulus generalization to a D-amphetamine cue.
Topics: Amphetamine; Analysis of Variance; Animals; Benzodiazepines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Corpus Striatum; Cues; Dopamine; Dopamine Antagonists; Generalization, Stimulus; Limbic System; Lisdexamfetamine Dimesylate; Male; Olanzapine; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tandem Mass Spectrometry; Time Factors | 2016 |
Cortical high gamma network oscillations and connectivity: a translational index for antipsychotics to normalize aberrant neurophysiological activity.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Brain Waves; Central Nervous System Stimulants; Cerebral Cortex; Clozapine; Dizocilpine Maleate; Electroencephalography; Excitatory Amino Acid Antagonists; Male; Nerve Net; Olanzapine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Risperidone | 2017 |
Effects of a novel M4 muscarinic positive allosteric modulator on behavior and cognitive deficits relevant to Alzheimer's disease and schizophrenia in rhesus monkey.
Topics: Alzheimer Disease; Amphetamine; Animals; Association Learning; Behavior, Animal; Central Nervous System Stimulants; Cholinergic Agents; Cognition Disorders; Hyperkinesis; Macaca mulatta; Male; Motor Activity; Olanzapine; Orientation; Receptor, Muscarinic M4; Schizophrenia; Schizophrenic Psychology | 2021 |